IMPORTANT LEGAL NOTICE - The information on this site is subject to adisclaimerand acopyright notice
 
Contact   |   Search  
European Research 2002

ERA logo

European Research 2002

Home page

   

Other conferences and events

FP6 logo

Sixth Framework
Programme 
(2002-2006)

  
Why European  Research?

    

    

European Research 2002

The European Research Area and the Framework Programme

Brussels, 11-12-13 November 2002

Exhibition

4. Genomics and biotechnology for health

Stand title

Combinatorial biosynthesis

Contact(s)

Lastname

Ylihonko

Kristiina

+358 227 41450

kristiina.ylihonko@galilaeus.fi; tero.kunnari@galileus.fi

Firstname

Telephone

E-mail

Description of the activities presented on the stand

This project stand will be devoted to the presentation of the ongoing "Combinatorial biosynthesis: generation of novel therapeutic substances by combining genes from actinomycetes and cyanobacteria" project. The visitors will gain insights into recent developments and will be able to meet a key player actively involved with the activities.

 

Stand title

Tissue engineering/repair

Contact(s)

Lastname

El Haj

Alicia

+44 1782 554253

bea17@keele.ac.uk; secretary: bea04@keele.ac.uk

Firstname

Telephone

E-mail

Description of the activities presented on the stand

This project stand will be devoted to the presentation of the ongoing "Biomechanical interactions in tissue engineering and surgical repair" project. The visitors will gain insights into recent developments and will be able to meet a key player actively involved with the activities.

 

Stand title

Ribosome Inhibitors

Contact(s)

Lastname

Wintermeyer

Nyborg

Firstname

Wolffgang

Jens

Organisation

University of Witten -Herdecke

University of Aarhus, Dept. Molecular, Structural Biology

Address

Institute of Molecular Biology

Gustav Wieds Vej 10C

Postal code-City

58448 - Witten

8000 - Aarhus

Country

Germany

Denmark

Telephone

+ 49 2302 669140/1

+ 45 8 9425257

Fax

+ 49 2302 669117

+ 45 8 6123178

E-mail

Winterme@uni-wh.de

Jnb@imsb.au;dk

Description of the activities presented on the stand

The general strategy of the project ‘Ribosome Inhibitors’ is to use the protein translation apparatus as a target for the development of new effective antimicrobials without cross-resistance to existing antibiotics. Advanced high-throughput screening assays are combined with crystal structure determination of inhibitor complexes with potential targets (ribosomes and translation factors) to identify new lead compounds. Inhibition potential is studied in established and new assay systems. Emphasis is placed on multi-resistant organisms causing infections that present particular public health problems.

 

Stand title

Preventing Heart Attack

Contact(s)

Lastname

Cullen

Lorkowski

Firstname

Dr. Paul

Dr. Stefan

Organisation

University of Münster, Institute of Arteriosclerosis Research

University of Münster, Institute of Arteriosclerosis Research

Address

Domagkstrasse 3

Domagkstrasse 3

Postal code-City

48149 - Münster

48149 - Münster

Country

Germany

Germany

Telephone

+49 251 8355734

+49 251 8352072

Fax

+49 251 9801389

 

E-mail

cullen@uni-muenster.de

lorkost@uni-muenster.de

Description of the activities presented on the stand

Presentation of poster documenting activities of Macrophage Function and Stability of the Atherosclerotic Plaque consortium during the Fifth Framework Program

 

Stand title

Cortical Development

Contact(s)

Lastname

Goffinet

André

Université Catholique de Louvain

Avenue E. Mounier, 73 PO Box 82

1200 - Bruxelles

Belgium

32 2 7647386

32 2 7647430

Andre.Goffinet@gede.ucl.ac.be

Firstname

Organisation

Address

Postal code-City

Country

Telephone

Fax

E-mail

Description of the activities presented on the stand

A better understanding of the mechanisms that control the development of the cerebral cortex is requisite to the prevention and treatment of many neurological and mental disorders such as brain malformations, learning disabilities and behavioural disorders. This consortium brings together complementary expertises in molecular and cellular techniques to address the key questions of the generation of cortical neurons, of radial and tangential neuronal migration, the formation of cortical layers, the differentiation of the various cortical areas and the formation of connections.

 

Stand title

Genetics of EU Twins (GENOMEUTWIN)

Contact(s)

Lastname

Peltonen

Leena

National Public Health Institute

PO Box 104

00251 - Helsinki

Finland

+358 9 47448393

+358 9 47448480

Leena.peltonen@ktl.fi

Firstname

Organisation

Address

Postal code-City

Country

Telephone

Fax

E-mail

Description of the activities presented on the stand

Studies of European volunteer twins to identify genes involved in common diseases

Because of their identical genetic make up, twins represent an invaluable group for medical researchers to search for the genetic origins of common diseases. This project will network the major "twin registries" of Europe and the top researchers in the field. This approach will considerably increase the chances of identifying the genetic origins of common diseases such as cardiovascular disease and the results of the research should open the way for development of new diagnostic tools and new therapies.

 

Stand title

Integrated project in FP5 (SPINE)

Contact(s)

Lastname

Stuart

David

Division of Structural Biology, The Henry Wellcome Building for Genomic Medicine, University of Oxford

Roosevelt Drive

Oxford, OX3 7BN

United Kingdom

+ 44 1865 287546

+ 44 1865 287547

Dave@strubi.ox.ac.uk

Firstname

Organisation

Address

Postal code-City

Country

Telephone

Fax

E-mail

Description of the activities presented on the stand

The SPINE FP5 Integrated Project brings together expertise from all over Europe in an attempt develop high throughput technologies to solve the structures of 500 proteins relevant to human health. SPINE will target the structures of a set of human proteins implicated in disease states, in particular cancer, and neurodegenerative diseases, together with proteins from a set of pathogenic viruses and bacteria, including Herpes viruses and Mycobacter tuberculosis.

 

Stand title

Integrated projects in FP5 (EUMORPHIA)

Contact(s)

Lastname

Brown

Stephen

MRC Mammalian Genetics Unit

Harwell, Oxfordshire

OX11 0RD

United Kingdom

+ 44 1235 834541

+ 44 1235 824542

s.brown@har.mrc.ac.uk

Firstname

Organisation

Address

Postal code-City

Country

Telephone

Fax

E-mail

Description of the activities presented on the stand

EUMORPHIA is an integrated research programme involving development of new approaches in phenotyping, mutagenesis and informatics leading to improved characterisation of mouse models for the understanding of human physiology and disease. The focus will be on development, standardisation and dissemination of primary and secondary phenotyping protocols for all body systems in the mouse. The project will pilot novel approaches to gene-driven mutagenesis and will be supported by new informatics tools for the acquisition, dissemination and querying of phenotype data.

 

Stand title

EDCTP

Contact(s)

Lastname

Trilla

Antoni

Fundació Clinic - Hospital Clinic Of Barcelona

Villarroel 170

08036 - Barcelona

Spain

+34 932 275754

+34 934 515-272

atrilla@clinic.ub.es

Firstname

Organisation

Address

Postal code-City

Country

Telephone

Fax

E-mail

Description of the activities presented on the stand

The European and Developing Countries Clinical Trials Partnership goals are to increase the effectiveness of EU investment in clinical trials for interventions against AIDS, TB and Malaria. EDCTP will be distinguished by its long-term relationship with the DCs, and the proposal to form the EDCTP as a true North-South partnership. All EU Member States and Norway, along with scientists from Sub-Saharan African countries are working for the EDCTP establishment by 2003.

The final aim is to develop a long term sustainable network of Good Clinical Practice clinical trials sites in sub-Saharan Africa.

 

Stand title

Poverty-related diseases/TB Vaccine

Contact(s)

Lastname

Gicquel

Brigitte

Unité de Génétique Mycobactérienne - Institut Pasteur

25 Rue du Dr. Roux

75724 - Paris Cédex 15

France

+33-1-45-68-88-28

+33-1-45-68-88-43

bgicquel@pasteur.fr

Firstname

Organisation

Address

Postal code-City

Country

Telephone

Fax

E-mail

Description of the activities presented on the stand

TB Vaccine cluster

An academic-industrial consortium (38 partners) was established, based on 4 component projects: Preclinical studies of vaccine candidates, Generation of novel live attenuated vaccines, Characterisation of non-protein antigens, and Understanding the immunological mechanisms of protection.

Several new vaccine candidates developed by the consortium were tested in different animal models and the most promising ones are now ready to be advanced to phase I clinical trials.

 

Stand title

Poverty-related diseases/EuroVac

Contact(s)

Lastname

Liljeström

Peter

Microbiology and Tumorbiology Centre, Karolinska Institutet

Nobels Väg 16

171 77 - Stockholm

Sweden

+46 8 4572550

+46 8 310 848

peter.liljestrom@mtc.ki.se

Firstname

Organisation

Address

Postal code-City

Country

Telephone

Fax

E-mail

Description of the activities presented on the stand

European Vaccine Effort Against HIV/AIDS

• To bring European preventive HIV vaccines to Phase I clinical trials, using attenuated live vaccinia virus as priming and recombinant envelope protein as boosting.

• To compare combinations of live pox vectors, envelope proteins and DNA and Semliki Forrest Virus replicon based vaccines.

Expected Results:

• Improvement of vaccine efficacy to develop candidate products for Phase II testing.

• Identification of HIV epitopes that illicit the best immune responses.

• Improvement of immune responses through development of new antigen formulations and adjuvants.

What's new?  |  Top